The chemokine receptor CXCR3 is preferentially expressed by Th1 cells and critically involved in their recruitment to inflamed tissue. In a mouse model of immune-mediated liver injury inducible by Con A, we investigated the role of CXCR3 in acute IFN-gmediated hepatitis as well as in tolerance induction, which has been shown to depend on IL-10-producing CD4 + CD25 + Foxp3 + regulatory T cells (Tregs). Induction of Con A hepatitis resulted in increased intrahepatic expression of the CXCR3 ligands CXCL9, CXCL10, and CXCL11. CXCR3 2/2 mice developed a more severe liver injury with higher plasma transaminase activities and a more pronounced Th1/Th17 response compared with wild-type (wt) animals upon Con A injection. Moreover, CXCR3 2/2 mice did not establish tolerance upon Con A restimulation, although Tregs from CXCR3 2/2 mice were still suppressive in an in vitro suppression assay. Instead, Tregs failed to accumulate in livers of CXCR3 2/2 mice upon Con A restimulation in contrast to those from wt animals. Con A-tolerant wt mice harbored significantly increased numbers of intrahepatic CXCR3 + Tbet + Tregs that produced IL-10 compared with nontolerant animals. IFN-g deficiency or anti-IFN-g Ab treatment demonstrated
that conversion to CXCR3 + T-bet + Tregs depended on a Th1 response. Accordingly, in an immunotherapeutic approach, CD4 + CD25 + Foxp3 + Tregs from Con A-pretreated CXCR3-deficient mice failed to protect against Con A-induced hepatitis, whereas
Tregs from Con A-tolerant wt mice allowed CXCR3-deficient mice to recover from Con A hepatitis. In summary, CXCR3 + T-bet + IL-10 + Tregs are generated in the liver in dependence of IFN-g, then disseminated into the organism and specifically migrate into the liver, where they limit immune-mediated liver damage. The Journal of Immunology, 2011, 186: 000-000.
C hemokines mediate migration of immune cells into infected or inflamed tissue to initiate effective immune responses (1) . T cell subsets express specific patterns of chemokine receptors, resulting in migration capacities that depend on T cell function. CD4 + Th1 cells are characterized by expression of CCR5, CXCR3, and CXCR6, whereas specific chemokine receptor expression by regulatory T cells (Tregs) is still obscure.
Tissue infiltration of T cells expressing high levels of CXCR3 depends on IFN-g-induced release of the CXCR3 ligands CXCL9, CXCL10, or CXCL11 (1). CXCR3 and its ligands are involved in the pathogenesis of various autoimmune diseases (2) , but also in acute allograft rejection (3) . Accordingly, CXCR3-deficient mice show reduced trafficking of effector T cells into the kidney, resulting in less renal injury (4) . However, studies using CXCR3-deficient mice have generated controversial results relating to disease severity in models of multiple sclerosis (2) . Therefore, CXCR3-expressing T cells might exert either protective or deleterious functions, depending on which organ is affected.
Interestingly, CXCR3 is not only expressed on Th1 cells, but also on non-lymphoid tissue-homing CD4 + CD25 + Tregs besides high levels of CD103, CCR5, CCR4, and CCR8 (5) , suggesting that Tregs and CD4 + effector T cells might exhibit overlapping receptor expression profiles. Indeed, CXCR3 expression on Tregs induced by an acute systemic Th1 response has recently been shown to depend on the Th1-specific transcription factor T-bet, because T-bet-deficient mice completely lack CXCR3 + Foxp3 + Tregs (6) . Hence, enhancement of Treg recruitment into inflamed tissue might improve the direct interaction with effector T cells or might modify APCs, thus limiting autoimmune-mediated tissue damage. In contrast to inflammation-seeking Tregs, lymphoid tissue-homing Tregs preferentially express CCR7 and CD62L, which allows them to control naive CD4 + T cell proliferation and homing/recirculation (1) .
With reference to liver pathologies, several studies on human hepatitis C virus infection have demonstrated that high CXCR3 expression correlates with viral clearance and liver damage (7) . Moreover, intrahepatic CXCR3 high CCR7
low Tregs, representing an activated, tissue-infiltrating phenotype, were identified in patients with autoimmune liver diseases (8) . However, the functional role of CXCR3 has not yet been investigated in experimental models of Th1-related liver disease. Therefore, we studied the impact of CXCR3 in the well-established mouse model of T cell-mediated liver injury inducible by Con A (9), which depends on activated CD4 + T cells, NKT cells, and Kupffer cells and is mediated by release of the proinflammatory cytokines IFN-g (10) and TNF-a, whereas IL-10 is protective (11) . Immune pathology in this model shares certain features with autoimmune hepatitis, specifically: relevance of CD4 + T cells, genetic prevalence of certain mouse strains in terms of susceptibility, gender-related differences, and immunosuppression during remission. We have recently described that IL-10-producing CD4 + CD25 + Foxp3 + Tregs, but not immuneregulatory NKT cells, mediate long-lasting tolerance against Con A restimulation that develops 8 d after the first Con A injection and is characterized by suppression of the Th1/Th17 responses and liver damage (12) . Moreover, Tregs from tolerant mice have a higher immunosuppressive activity in vivo and in vitro compared with those from nonpretreated animals.
Taken together, the critical role of CXCR3 for recruitment of Th1 cells on the one hand and for immunoregulatory T cells on the other hand prompted us to investigate the role of CXCR3 in both Con A-induced Th1-mediated hepatitis and Con A tolerance. Using CXCR3-deficient mice, we have demonstrated in this study that the immune-regulatory effect of CXCR3 expressed by T-bet-positive IL-10-producing Tregs seems to overwrite its function with respect to a liver-specific Th1 response, because CXCR3-deficient mice developed more severe liver injury and failed to develop Con A tolerance, which corresponded to reduced Treg recruitment into the liver.
In conclusion, CXCR3 + T-bet + IL-10 + Tregs specifically recruited to the liver might represent a novel option for improved therapy of autoimmune liver disease.
Materials and Methods

Mice
Male CD45.1-expressing congenic mice kindly provided by Dr. Andrea Horst (Clinical Chemistry), as well as male C57BL/6 wild-type (wt),
, and CXCR3 2/2 (4) mice, all aged 6-10 wk, were obtained from the animal facilities of the University Medical Center Hamburg-Eppendorf. Animals received humane care according to guidelines of the National Institutes of Health in Germany. Experiments were approved by the institutional review board Behörde für Soziales, Familie, Gesundheit und Verbraucherschutz.
Animal treatments
Con A (5-15 mg/kg; Sigma-Aldrich, Munich, Germany) or saline was administered i.v. followed by Con A restimulation 8 
Determination of plasma transaminase and cytokine levels
Liver injury was quantified by measurement of plasma activities of alanineaminotransferase (ALT) 8 h after Con A administration using the COBAS Mira System (Roche Diagnostic, Mannheim, Germany). ELISAs (TNF-a, IFN-g, IL-2, IL-6, IL-10, IL-17) were performed as described previously (12) .
Expression analysis of chemokines/cytokines
Total RNA was reversely transcribed, followed by RT-PCR using the BioRad CFX96 real-time system (Bio-Rad) and ABsoluteQPCR SYBR mix (Thermo Fisher). Primer pairs were used as described previously (4, 12) . Relative mRNA levels were calculated after normalization to b-actin or GAPDH, using the CFX96 Manager software.
Isolation of various cell subpopulations
Liver sinusoidal endothelial cells (LSECs) were isolated using anti-CD146 MicroBeads (Miltenyi Biotec, Bergisch Gladbach, Germany) according to the manufacturer's instructions. Primary hepatocytes were isolated as described previously (13) . LSECs and hepatocytes were incubated with 100 ng/ml rIFN-g (PeproTech, Hamburg, Germany) in vitro for 24 h or isolated ex vivo 2 h upon Con A treatment. Spleen, liver, and lymph nodes (LN) were passed through 100-mm nylon meshes, which yielded in single-cell suspensions. Hepatocytes were removed by density gradient prior to erythrocyte lysis. To isolate splenic CD4 + CD25
+ Tregs and responder T cells, splenocytes were sorted using a combination of MACS and FACS (BD FACSAria; BD Biosciences) as described previously (12) to achieve highly purified CD4 + CD25 + Tregs (∼98%).
Flow cytometric analysis
A total of 1 3 10 6 leukocytes were stained using standard protocols. The following anti-mouse mAbs were used: CD45.2-biotin (clone 104), CD4-FITC (GK1.5), CD25-PE-Cy7 (PC61), NK1.1-PE (PK136), CD3ε-CyChrome (145-2C11; all BD Pharmingen), CXCR3-allophycocyanin, Foxp3-PE-Cy5 (FJK-16s), T-bet-PE (ebio4B10; all eBioscience/Natutec, Frankfurt, Germany), and streptavidin-Pacific Blue (Invitrogen, Karlsruhe, Germany). Data were recorded using the BD FACSCanto II system and BD FACSDiva software (BD Biosciences).
Statistical analysis
Data are presented as mean values 6 SEM. Results were analyzed using Student's t test, Tukey's test, or log-rank test. All p values .0.05 were considered significant.
Results
Increased intrahepatic expression of CXCR3 ligands upon Con A challenge
Analysis of the basal expression of the CXCR3-binding ligands CXCL9, CXCL10, and CXCL11 revealed that all three chemokines were constitutively expressed in liver tissue in contrast to very low expression levels in kidney (except for CXCL10) and heart tissue ( Fig. 1A) . To correlate IFN-g levels and intrahepatic expression of the IFN-g-inducible CXCR3-binding ligands CXCL9-11 during Con A-induced inflammation, wt mice were treated with 12 mg/kg Con A or saline as control. Liver tissue samples and cardiac blood were taken after 1.5, 3, 6, and 8 h. IFN-g expression in plasma (Fig. 1B ) and liver tissue (Fig. 1C ) correlated with increased intrahepatic expression of CXCL9, CXCL10, or CXCL11 upon Con A injection ( Fig. 1D-F ; time point = 0: expression level set to 1). To strengthen the chemoattractant function of resident liver cells (14-16), we either cultivated primary hepatocytes or LSECs isolated from wt mice 2 h upon Con A challenge ex vivo, or we incubated such cells from untreated wt mice with rIFN-g in vitro.
Both cell populations strongly expressed CXCL9-11 ex vivo (Fig.  1G ) or in vitro compared with control cells (Fig. 1H) , thus demonstrating their capacity to produce IFN-g-inducible chemokines for recruitment of CXCR3-expressing T cells. As the liver constitutively expresses CXCL9-11, we compared the frequencies of 3B ). Aggravated liver damage was accompanied by a pronounced increase of plasma levels of the proinflammatory cytokines TNF-a, IL-17, IL-6, and IFN-g as well as by reduced IL-10 production (Fig. 3C ). Accordingly, intrahepatic mRNA expression of the proinflammatory cytokines IFN-g, IL-17, and IL-6 was significantly upregulated in CXCR3 2/2 mice compared with wt mice upon Con A challenge ( 
Loss of Con A tolerance in CXCR3
2/2 mice correlates with decreased intrahepatic numbers of Tregs
Recently, we reported that IL-10-producing Tregs mediate tolerance against Con A restimulation by suppressing the Th1 response and attenuating liver pathology (12) . It has also been shown that CXCR3 + Tregs preferentially migrate into the inflamed liver (8, 17, 18) . We therefore investigated whether CXCR3 2/2 mice have defective immunoregulation by studying their ability to develop Con A tolerance. As shown in Fig. 3E , a sublethal dose of Con A (5 mg/kg) not only failed to induce tolerance toward Con A restimulation in CXCR3 2/2 mice but also even aggravated liver damage in these animals ( Fig. 3E , right panel, black bar). Although low-dose pretreatment of wt mice with 5 mg/kg only induced a slight reduction of plasma transaminase activities (Fig.  3E , middle bars), pretreatment with 10 mg/kg significantly attenuated Con A-induced liver injury (Fig. 3E, left bars) . These results suggest that a threshold of immune activation is necessary A, Liver (L), kidney (K), and heart (H) tissue were isolated from saline-treated wt mice. Constitutive expression of CXCL9, CXCL10, and CXCL11 was measured by quantitative realtime RT-PCR (qRT-PCR). The wt mice were treated with Con A or saline. Plasma IFN-g levels were determined by ELISA (B). Intrahepatic expression of IFN-g (C), CXCL9 (D), CXCL10 (E), and CXCL11 (F) was measured from total RNA by qRT-PCR. Samples were taken 1.5, 3, 6, or 8 h after Con A challenge. Chemokine expression of saline-treated wt mice was set to 1. The experiment was repeated once with similar results (mean 6 SEM; n = 4). Primary hepatocytes and LSECs were isolated 2 h upon Con A challenge (G) or isolated from untreated wt mice (H) and incubated in triplicate with 100 ng/ml rIFN-g for 24 h. CXCL9-11 mRNA expression was measured by qRT-PCR.
for the development of Con A tolerance in wt mice and that tolerance is not inducible in the absence of CXCR3. According to the high plasma transaminase activities in CXCR3 2/2 mice upon Con A restimulation, proinflammatory cytokine production was not reduced in either plasma or liver tissue compared with saline-pretreated CXCR3-deficient mice both in plasma and liver tissue (Fig. 3F, 3G ). Also in accordance with our previous results (12), IL-2 production was still suppressed in plasma (Fig. 3F ) and liver tissue (Fig. 3G ) of Con Apretreated CXCR3-deficient mice upon Con A rechallenge, indicating that impairment of IL-2 production occurred independently of CXCR3 and failed to correlate with suppression of immune pathology. The anti-inflammatory and protective cytokine IL-10 is mainly produced by Tregs in Con A-tolerant mice (12) . Interestingly, CXCR3-deficient mice produced less IL-10 than wt mice upon a single i.v. Con A injection (Fig. 3C , black bar) and failed to establish tolerance-induced production of IL-10 both in plasma and liver tissue (Fig. 3F, 3G ) upon Con A restimulation. These findings correlate very well with the reduced numbers of Tregs found in livers of both saline-and Con A-treated CXCR3-deficient mice compared with wt mice on day 8 (i.e., at the time point of tolerance induction) (Fig. 4A, 4B) . However, the number Fig. 4C : quantification of Treg numbers). Moreover, Treg frequencies were significantly increased in livers of Con A-tolerant wt mice 2 h after Con A restimulation, whereas this effect was not detectable in CXCR3 2/2 mice (Fig. 4D) . In contrast, livers of both saline-and Con A-treated CXCR3 www.jimmunol.org were adoptively transferred from Con A-tolerant wt mice into wt mice 24 h prior to Con A challenge reduced liver injury in contrast to Tregs transferred from CXCR3-deficient mice (Fig. 5A) . Moreover, Tregs from Con A-tolerant wt mice also protected CXCR3-deficient mice against Con A hepatitis (Fig. 5B) , again providing evidence for the high suppressive capacity of Con Aprimed Tregs.
To confirm the impaired migration capacity of CXCR3-deficient Tregs, we performed an in vivo migration experiment using CD45.1-expressing congenic mice. To recover the injected CD45.2 + cells, it was necessary to transfer 10 3 10 6 splenic Tregs from either wt or CXCR3 2/2 mice 24 h prior to Con A challenge.
Purity and CD25/Foxp3 expression of the injected cells were controlled by FACS analysis (.90%). Eight hours upon Con A treatment, CD45.2 + cells were identified in CD45.1 + congenic mice. In fact, CXCR3-deficient Tregs were less frequent in livers of congenic mice compared with wt Tregs (0.14 6 0.03% versus 0.25 6 0.04% among total intrahepatic leukocytes, Fig. 5C 
Increased expression of the transcription factor T-bet in Tregs isolated from Con A-tolerant mice
Recently, it has been shown that CXCR3 expression on Tregs depends on the Th1-specific transcription factor T-bet, because Tbet-deficient mice completely lack Foxp3 + CXCR3 + Tregs (6). To identify whether Tregs had been converted to T-bet + Tregs following induction of the Th1 response in the liver, we analyzed Tbet protein expression by intrahepatic Tregs ex vivo using intracellular FACS staining 8 d after the first Con A injection. Tregs In addition, T-bet mRNA expression was also measured in highly purified splenic CD4 + CD25 + Tregs from saline-or Con A-treated wt animals and, as a control, in splenic CD4 + responder cells upon in vitro stimulation. Intracellular Foxp3 expression by Tregs was controlled by flow cytometry (.95%). Interestingly, therapeutically efficient Tregs (compare Fig. 5 ) primed in a Th1 environment, as a result of the in vivo Con A challenge, exhibited significantly increased T-bet expression upon in vitro restimulation, whereas T-bet expression in Tregs from naive mice was close to the detection limit (Fig. 6C, left graph) . Therefore, Tregs from Con A-tolerant mice significantly overexpressed the immunosuppressive cytokine IL-10 compared with responder cells and Tregs from saline-treated mice (Fig. 6C, right graph) .
To demonstrate the relevance of an intact Th1 immune response for inducing T-bet expression in Tregs from Con A-tolerant mice, we either injected a neutralizing Ab against IFN-g 1 h prior to Con A challenge or we used IFN-g 2/2 mice. The frequencies of 
Discussion
The liver appears to be a privileged organ regarding induction of immunological tolerance due to its special position linking the gastrointestinal tract and the systemic venous circulation. Hence, the liver assumes the function of a scavenger organ by clearance of foreign Ags from the gut without inflammation, and therefore, it probably harbors organ-specific or dominant immunoregulatory mechanisms (19, 20) . Moreover, liver transplants are often not rejected despite MHC discrepancies and even in the absence of immunosuppression (21) . However, hepatotropic pathogens have to be eliminated to prevent persistence and chronic infections (22) . To fulfill these functions, the liver contains both resident and recruited lymphocytes. In the healthy liver, most lymphocytes are activated and express much higher levels of CXCR3 and CCR5 than circulating memory T cells (23) . These T cells are not necessarily Th1 cells, because patients with autoimmune liver diseases harbor CXCR3 high CCR7 low Tregs in the inflamed liver in contrast to a predominance of CXCR3 low CCR7
high Tregs in the peripheral blood (8) . Accordingly, as shown in this study, livers from untreated mice contain higher frequencies of both CXCR3 + CD4
+ T cells and CXCR3 + Tregs compared with secondary lymphoid organs or blood.
In the current study, we have demonstrated a beneficial role for CXCR3 in Th1-mediated acute hepatitis as well as in Con A tolerance. It is well known that several hepatic cell populations www.jimmunol.org secrete specific chemokines upon IFN-g activation (23) . We identified hepatocytes and LSECs as CXCR3 ligand-producing cells upon Con A challenge in vivo and thus demonstrated their involvement in CXCR3 + lymphocyte recruitment. In this context, Jaruga et al. (16) reported that IFN-g treatment induces the expression of several chemokines in primary hepatocytes, LSECs, and Kupffer cells through activation of STAT1, STAT3, and IFN regulatory factor 1. Accordingly, the lack of IFN regulatory factor 1 resulted in protection against Con A-induced hepatitis due to suppressed chemokine expression (among others, CXCL9, CXCL10, and CXCL11) and decreased leukocyte infiltration into the liver (16) .
To elucidate the role of CXCR3 during Th1-mediated Con Ainduced liver injury, we used CXCR3-deficient mice. Interestingly, CXCR3-deficient mice were highly susceptible toward Con A in contrast to wt mice as a result of an increased intrahepatic frequency of disease-mediating NKT cells. This suggests that CXCR3 has a protective function in acute immune-mediated liver injury. In contrast to our findings, Jiang et al. (24) reported that NKT cells were virtually absent in CXCR3-deficient mice (wt:
20% versus CXCR3
2/2 : 0.8%). The reason for this discrepancy is unclear. One explanation might be that Jiang et al. (24) used mice backcrossed from 129J mice for five generations. In 129J mice, the marker NK1.1 is not expressed on NK and NKT cells. Hence, FACS analysis using anti-CD3 and anti-NK1.1 Abs for detection of NKT cells is not applicable in some mouse strains. We used mice backcrossed for more than seven generations to the C57/ BL6 background (4) and compared knockout mice to age-and sex-matched wt controls. Moreover, in preliminary studies, Santodomingo-Garzon et al. (17) observed reduced hepatic NK + cell numbers in CXCR3-deficient mice. However, they did not mention which background and Abs were used for the determination of intrahepatic NK + cells in CXCR3-deficient mice. Interestingly, a further study demonstrated that the chemokine receptor CXCR3 is necessary to retain NKT cells in the thymus (25) . Hence, CXCR3 2/2 mice harbored an increased frequency of NKT cells in the periphery, in line with our results. It has been suggested that proinflammatory cytokines that are strongly induced upon the first Con A challenge (IFN-g, TNF-a, IL-17) might induce the generation and recruitment of specialized Tregs (26) . Indeed, a-galactosylceramide-induced, IFN-g-mediated specific activation of NKT cells has been shown to induce CXCL10 release, followed by selective recruitment of CXCR3-expressing Tregs into the liver (17) . This immediate recruitment of Tregs has also been observed in the Con A model as early as 24 h following the first injection (12) and 2 h upon Con A restimulation; however, it did not depend on NKT cells, because increased Treg frequencies were also detectable in Con A-tolerant CD1d 2/2 mice (Fig. 4F) mice due to Treg abnormalities. CXCR3-deficient mice were viable and fertile and showed no obvious developmental abnormalities compared with wt mice (4). Nevertheless, CXCR3-deficient mice failed to induce Con A tolerance in response to liver inflammation associated with reduced Treg infiltration compared with wt mice. Moreover, Tregs isolated from Con A-tolerant wt mice showed an increased expression of CXCR3, T-bet, and IL-10. The increased frequency of CXCR3 + Tbet + Tregs might result from the conversion of CXCR3 + effector T cells found predominantly in the liver of naive wt mice (Fig.  2C, 2D) . Recently, it has been shown that CXCR3 expression by Tregs seems to strictly depend on T-bet, because T-bet-deficient mice completely lack CXCR3 + Foxp3 + Tregs (6) . De novo T-bet expression in these Tregs was analyzed in a secondary lymphoid organ, namely in the spleen upon acute, systemic Th1-related inflammation induced by an anti-CD40 Ab. In this study, we have highlighted the role of CXCR3 + T-bet + Tregs in a tolerogenic milieu that develops in an affected target organ, the liver, in response to immune-mediated Th1-dependent liver disease. Accordingly, the current study demonstrates that CXCR3 expression was not induced in IFN-g-deficient T cells (31) or upon administration of a neutralizing anti-IFN-g Ab. It should be noted that untreated, naive IFN-g 2/2 mice harbored a reduced number of CXCR3 + T-bet + Tregs in the liver compared with naive wt mice (Fig. 6E) , which might be due to the general lack of IFN-g. This could lead to a decreased expression pattern of IFN-g-inducible CXCR3-binding ligands CXCL9, CXCL10, and CXCL11 and hence a reduced recruitment of CXCR3 + T cells in IFN-g
mice. The necessity of IFN-g for inducing CXCR3 expression has also been demonstrated by Nakajima et al. (31) , but only in an in vitro assay. Moreover, the increased frequency of CXCR3 + Tbet + Tregs in the liver of Con A-tolerant mice seems to be independent of NKT cells, because Con A-tolerant, NKT celldeficient CD1d 2/2 mice also displayed elevated numbers of intrahepatic CXCR3 + T-bet + Tregs (Fig. 6F, 6G ), confirming our previous results regarding NKT cell redundancy in our model of Con A tolerance (12) . Because the initial frequency of CXCR3 + Tbet + Tregs was reduced in naive CD1d 2/2 mice compared with wt mice (3.0 6 0.5% versus 10.8 6 1.0%), one could expect that NKT cells are essential for Treg recruitment under steady-state conditions as also shown by Santodomingo-Garzon et al. (17) . However, upon a strong inflammatory process, we detected a 5-fold increase of the CXCR3 + Treg subpopulation in Con Atolerant CD1d 2/2 mice, despite the lack of NKT cells.
Hence, our study considers distribution and migration of Treg subsets between target organ and secondary lymphoid organs. These novel findings emphasize the special role of the liver in the development of tolerance mediated by conversion to T-bet + CXCR3
+ Tregs. Thus, CXCR3 + Tregs primed in a Th1 microenvironment are specialized to inhibit Th1-mediated liver inflammation in a kind of a feedback loop, resulting in immunosuppression and Con A tolerance.
Remarkably, in a murine acute graft-versus-host disease model, transfer of CXCR3-transfected Tregs ameliorated liver disease, due to more pronounced migration and prolonged persistence of highly suppressive CXCR3 + Tregs within the liver (32) . These findings correlate very well with our data, because Tregs from Con A-pretreated CXCR3-deficient mice failed to protect against Con A-induced hepatitis in contrast to Tregs from Con A-tolerant wt mice, most probably because of the impaired migration capacity of CXCR3 2/2 Tregs. Intriguingly, Tregs from CXCR3-deficient mice even augmented the disease severity of Con A-induced hepatitis compared with Con A-challenged control mice, suggesting that firstly, Tregs from CXCR3-deficient mice might not be able to enter the inflamed liver, and, secondly, they might even block immunoregulatory functions mediated by APCs in the draining LN. However, CXCR3-deficient mice can be cured by Tregs isolated from Con A-tolerant wt mice, because these Tregs exhibit an intact and preferential migration capacity into the inflamed liver.
A very recent study has demonstrated that intrahepatic Tregs from chronically inflamed human tissue express high levels of CXCR3 and CCR4. In vitro adhesion assays argued for a role of CXCR3 in endothelial transmigration of isolated Tregs (18) . However, a functional role of CXCR3 related to the severity of liver diseases in vivo has never been described. We have clearly demonstrated that functional impairment of CXCR3 is associated with higher intrahepatic frequencies of In the past, clinical trials using low m.w. chemokine receptor antagonists for treatment of autoimmune and inflammatory disease have failed, although beneficial effects have been observed in animal models (33 
